GNAS, not a Highly Mutated Gene, Has Prognostic Significance and Carcinogenic Effects in Osteosarcoma
Cellular Physiology and Biochemistry · 2024
DOI: 10.33594/000000728 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Physiology and Biochemistry, 2024. Verfasst von Jin Qi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu 241001, Anhui …. Hauptthemen laut MEDLINE: Bone Neoplasms, Chromogranins, GTP-Binding Protein alpha Subunits, Gs, Mice, Nude. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Gefördert von: The Talent Introduction Science Foundation of Yijishan Hospital, Wannan Medical College, 2022 Anhui Provincial Institute of Translational Medicine Research Project, The Key Research Foundation of Wannan Medical College.
Abstract (Originalsprache)
Background/Aims: Osteosarcoma is a prevalent and aggressive primary malignant bone tumor affecting children and adolescents. Despite advancements in sequencing technologies, there remains a lack of reliable prognostic biomarkers and effective targeted therapies for osteosarcoma. This study focuses on identifying key prognostic genes, particularly the role of GNAS, in osteosarcoma progression.
Methods
Bioinformatics analyses were performed on osteosarcoma datasets from the Gene Expression Omnibus (GEO). Differential gene expression analysis, weighted correlation network analysis (WGCNA), and survival analysis identified potential prognostic hub genes. The expression and function of these genes were validated through immunohistochemistry and animal experiments. Specifically, the role of GNAS was investigated through siRNA-mediated knockdown in osteosarcoma cell lines and nude mice models.
Results
Five hub genes (PROP1, GNAS, CYP4F2, LHX3, CNGB1) were identified as significantly related to osteosarcoma prognosis. Among these, GNAS was found to be highly expressed in osteosarcoma tissues compared to normal tissues. Immunohistochemical analysis confirmed the elevated expression of GNAS in osteosarcoma samples. GNAS mutation analysis revealed a low mutation rate in osteosarcoma, suggesting its oncogenic role is independent of mutational status. Animal experiments demonstrated that knocking down GNAS significantly inhibited tumor growth and induced apoptosis in osteosarcoma cells.
Conclusion
GNAS is highly expressed in osteosarcoma and associated with poor prognosis, acting as an oncogene in osteosarcoma progression. Targeting GNAS could be a potential therapeutic strategy for osteosarcoma. Further studies on GNAS-related signaling pathways may provide deeper insights into the molecular mechanisms driving osteosarcoma malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu 241001, Anhui Province, China.
- Human Anatomy Experimental Training Center, School of Basic Medicine Science, Wannan Medical College, Wuhu 241001, Anhui Province, China.
- Shanghai Jiao Tong University Affiliated Sixth People's Hospital South Campus, Shanghai 201400, China, :15370890937@163.com.
Förderung
- The Talent Introduction Science Foundation of Yijishan Hospital, Wannan Medical College
- 2022 Anhui Provincial Institute of Translational Medicine Research Project
- The Key Research Foundation of Wannan Medical College
Zitieren
APA
Qi, J., Huang, Y., & Bian, Y. (2024). GNAS, not a Highly Mutated Gene, Has Prognostic Significance and Carcinogenic Effects in Osteosarcoma. Cellular Physiology and Biochemistry. https://doi.org/10.33594/000000728
Vancouver
Qi J, Huang Y, Bian Y. GNAS, not a Highly Mutated Gene, Has Prognostic Significance and Carcinogenic Effects in Osteosarcoma. Cellular Physiology and Biochemistry. 2024. doi:10.33594/000000728
BibTeX
@article{Qi2024,
author = {Qi, Jin and Huang, Yanjiao and Bian, Yaogang},
title = {GNAS, not a Highly Mutated Gene, Has Prognostic Significance and Carcinogenic Effects in Osteosarcoma},
journal = {Cellular Physiology and Biochemistry},
year = {2024},
doi = {10.33594/000000728}
}
EUVIMED